CXCL12 and psoriasis: Both CXCL12 inhibition and CXCR4 antagonism ameliorated psoriasis-like lesions in IMQ-treated mice (Fig. 8a), including epidermal thickness (Fig. 8b), and proportion of infiltrating Ly6G+CXCR4hi neutrophils (Fig. 8c).